ImmunityBio Inc. Common Stock vs Ondas Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Ondas Inc. Common Stock trades at $6.96 (market cap $4.19B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.5× Ondas Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| IBRX | ONDS | |
|---|---|---|
Market Cap | $10.33B | $4.19B |
Volume | 11,745,198 | 61,559,166 |
Sector | Health | Technology |
52-Week High | $11.55 | $14.01 |
52-Week Low | $1.98 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $2.82B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →